Living and dying well with end-stage liver disease: Time for palliative care?

Hepatology

Volumn 55, Issue 6, 2012, Pages 1650-1651

  Boyd, Kirsty ^a   Kimbell, Barbara ^a   Murray, Scott ^a   Iredale, John ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; CYTOCHROME; FENTANYL; HYDROMORPHONE; MORPHINE; OPIATE; TRAMADOL;

CHRONIC PAIN; CONSTIPATION; DRUG METABOLISM; DYING; EDITORIAL; END STAGE LIVER DISEASE; FAMILY COUNSELING; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; MORBIDITY; PAIN; PALLIATIVE THERAPY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL CARE; SCORING SYSTEM; SIGNAL TRANSDUCTION; SPIRITUAL CARE; UNITED KINGDOM;

HUMANS; LIVER FAILURE; PALLIATIVE CARE; QUALITY OF LIFE; TERMINALLY ILL;

EID: 84861568302     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25621     Document Type: Editorial

References (21)

1. British Association for the Study of the Liver and British Society of Gastroenterology. A Time to Act: Improving Liver Health and Outcomes in Liver Disease. The National Plan for Liver Services UK 2009.
2. Moore K, Sheron N. Why we need a national strategy for liver disease. Br J Hosp Med (Lond) 2009; 70: 674-675.
3. Sanchez W, Talwalkar JA. Palliative care for patients with end-stage liver disease ineligible for liver transplantation. Gastroenterol Clin North Am 2006; 35: 201-219.
4. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;: 217-231.
5. Kalaitzakis E, Josefsson A, Bjornsson E. Psychological distress in patients with liver cirrhosis. Gastroenterology 2008; 134: A625.
6. Roth K, Lynn J, Zhong ZS, Borum M, Dawson NV. Dying with end stage liver disease with cirrhosis: insights from SUPPORT. J Am Geriatr Soc 2000; 48: S122-S130.
7. Iredale J. End-stage chronic liver disease: time to define a good death. HEPATOLOGY 2008; 47: 1799-1800.
8. Hope AA, Morrison S. Integrating palliative care with chronic liver disease care. J Palliat Care 2011; 27: 20-27.
9. Les I, Doval E, Flavia M, Jacas C, Cardenas G, Esteban R, et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol 2010; 22: 221-227.
10. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al. Factors associated with poor health related quality of life of patients with cirrhosis. Gastroenterology 2001; 120: 170-178.
11. Bjørk IT, Nåden D. Patients' experiences of waiting for a liver transplantation. Nursing Inquiry 2008; 15: 289-298.
12. Murray S, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care. BMJ 2005; 330: 1007-1011.
13. World Health Organisation. WHO definition of palliative care. 2010. Available at:. Accessed on October 21, 2011.
14. NHS National End of Life Care Programme. Available at:. Accessed on October 21, 2011.
15. Scottish Government. Living and dying well: a national action plan for palliative and end of life care in Scotland. Available at:. Accessed on October 21, 2011.
16. Boyd K, Murray S. Recognising and managing key transitions in end of life care. BMJ 2010; 341: 649-652.
17. Boyd K, Murray S. Supportive and Palliative Care Indicators Tool (SPICT). Available at:. Accessed on October 21, 2011.
18. Benson GD, Koff RS, Tolman KG. The therapeutic use of acetaminophen in patients with liver disease. Am J Ther 2005; 12: 133-141.
19. Rhee C, Broadbent AM. Palliation and liver failure: palliative medications dosage guidelines. J Palliat Med 2007; 10: 677-685.
20. Tegeder I, Lotsch J, Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 1999; 37: 17-40.
21. Fox E, Landrum-McNiff K, Zhong ZS, Dawson NV, Wu AW, Lynn J. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. JAMA 1999; 282: 1638-1645.